We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+0.87%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$220M
AUM Growth
+$3.2M
Cap. Flow
+$2.23M
Cap. Flow %
1.02%
Top 10 Hldgs %
43.16%
Holding
72
New
2
Increased
21
Reduced
30
Closed
2

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$946K
2
PYPL icon
PayPal
PYPL
+$752K
3
META icon
Meta Platforms (Facebook)
META
+$646K
4
ABT icon
Abbott
ABT
+$591K
5
PAYC icon
Paycom
PAYC
+$242K

Top Sells

Rank Stock Value
1
FTV icon
Fortive
FTV
+$648K
2
APD icon
Air Products & Chemicals
APD
+$559K
3
LLTC
Linear Technology Corp
LLTC
+$309K
4
GILD icon
Gilead Sciences
GILD
+$217K
5
CMG icon
Chipotle Mexican Grill
CMG
+$103K

Sector Composition

Rank Sector Weight
1 Healthcare 23.48%
2 Technology 18.99%
3 Consumer Staples 14.95%
4 Industrials 9.98%
5 Consumer Discretionary 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
51
ExxonMobil
XOM
$644B
$545K 0.25%
6,050
-31
-0.5% -$2.71K
CLB icon
52
Core Laboratories
CLB
$488M
$522K 0.24%
4,350
– –
BIIB icon
53
Biogen
BIIB
$30B
$506K 0.23%
1,780
+40
+2% +$11.9K
MSFT icon
54
Microsoft
MSFT
$3.45T
$487K 0.22%
7,861
– –
PAYC icon
55
Paycom
PAYC
$7.64B
$444K 0.2%
9,860
+5,205
+112% +$242K
ESRX
56
DELISTED
Express Scripts Holding Company
ESRX
$440K 0.2%
6,380
+710
+13% +$50.9K
CSCO icon
57
Cisco
CSCO
$457B
$435K 0.2%
14,500
-199
-1% -$6.07K
GPC icon
58
Genuine Parts
GPC
$17.1B
$408K 0.19%
4,255
-25
-0.6% -$2.38K
CMA
59
DELISTED
Comerica
CMA
$351K 0.16%
5,157
– –
KHC icon
60
Kraft Heinz
KHC
$30.7B
$307K 0.14%
3,525
– –
IBM icon
61
IBM
IBM
$211B
$266K 0.12%
1,674
– –
TGT icon
62
Target
TGT
$65.6B
$265K 0.12%
3,675
– –
ETN icon
63
Eaton
ETN
$161B
$258K 0.12%
3,856
-500
-11% -$32.8K
T icon
64
AT&T
T
$159B
$247K 0.11%
7,598
– –
VZ icon
65
Verizon
VZ
$195B
$234K 0.11%
4,414
+95
+2% +$4.75K
BMY icon
66
Bristol-Myers Squibb
BMY
$133B
$229K 0.1%
+3,950
New +$216K
EMR icon
67
Emerson Electric
EMR
$83.9B
$227K 0.1%
4,057
– –
MO icon
68
Altria Group
MO
$114B
$225K 0.1%
3,307
– –
VSM
69
DELISTED
Versum Materials, Inc.
VSM
$200K 0.09%
+7,150
New +$178K
GCVRZ
70
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$4K ﹤0.01%
10,660
– –
FTV icon
71
Fortive
FTV
$17.9B
– –
-20,141
Closed -$648K
GILD icon
72
Gilead Sciences
GILD
$162B
– –
-2,750
Closed -$217K
1 2
3

Similar funds

TC
Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return
F
FIFTHDELTA London, United Kingdom $725M AUM 11.7% 1-Year Est. Return
SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
SCM
SKBA Capital Management San Francisco, California $728M AUM 12.18% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $729M AUM 15.61% 1-Year Est. Return
FAN
Financial Advisors Network Tustin, California $724M AUM 14.91% 1-Year Est. Return
TFHU
TLT Family Holdco ULC Toronto $724M AUM 24.23% 1-Year Est. Return
AGAM
Avalon Global Asset Management San Francisco, California $724M AUM 52.97% 1-Year Est. Return

Dillon & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Dillon & Associates held 72 positions worth $220M, up 1.5% from $217M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Dillon & Associates's Q4 2016 filing shows 2 new, 21 increased, 30 reduced and 2 closed positions. Its largest new stake was Bristol-Myers Squibb: 3,950 shares worth $229K. The largest sale was Fortive, an estimated $648K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Consumer Staples.

  • Dillon & Associates's largest Q4 2016 buy was Bristol-Myers Squibb: 3,950 shares worth $229K.
  • Dillon & Associates added most to Novo Nordisk in Q4 2016, an estimated $946K increase.
  • Dillon & Associates's biggest Q4 2016 reduction was Air Products & Chemicals, cutting an estimated $559K.
  • Dillon & Associates fully exited Fortive in Q4 2016, selling an estimated $648K.
  • Dillon & Associates's ten largest holdings make up 43% of its $220M portfolio in Q4 2016.
  • Dillon & Associates opened 2 new positions and closed 2 in Q4 2016.
  • Dillon & Associates's portfolio value rose 1.5% quarter-over-quarter to $220M.

Based on Dillon & Associates's 13F filing for Q4 2016, filed 2 Feb 2017.